Reported Earnings • Feb 01
Third quarter 2026 earnings released: EPS: CA$0 (vs CA$0.001 loss in 3Q 2025) Third quarter 2026 results: EPS: CA$0 (improved from CA$0.001 loss in 3Q 2025). Net loss: CA$28.9k (loss narrowed 81% from 3Q 2025). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 33% per year, which means it is significantly lagging earnings. New Risk • Dec 10
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Canadian stocks, typically moving 20% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (20% average weekly change). Earnings have declined by 8.2% per year over the past 5 years. Shareholders have been substantially diluted in the past year (59% increase in shares outstanding). Revenue is less than US$1m (CA$98k revenue, or US$71k). Market cap is less than US$10m (CA$5.06m market cap, or US$3.65m). Reported Earnings • Nov 02
First half 2026 earnings released: CA$0.006 loss per share (vs CA$0.005 loss in 1H 2025) First half 2026 results: CA$0.006 loss per share (further deteriorated from CA$0.005 loss in 1H 2025). Net loss: CA$831.7k (loss widened 120% from 1H 2025). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has fallen by 16% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 01
First quarter 2026 earnings released: CA$0.002 loss per share (vs CA$0 in 1Q 2025) First quarter 2026 results: CA$0.002 loss per share (further deteriorated from CA$0 in 1Q 2025). Net loss: CA$271.6k (down CA$290.8k from profit in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings. Aankondiging • Jul 03
Digital Commodities Capital Corp. Auditor Raises 'Going Concern' Doubt Digital Commodities Capital Corp. filed its Annual on Jul 01, 2025 for the period ending Feb 28, 2025. In this report its auditor, Davidson & Company, gave an unqualified opinion expressing doubt that the company can continue as a going concern. Reported Earnings • Jul 02
Full year 2025 earnings released: CA$0.022 loss per share (vs CA$0.022 loss in FY 2024) Full year 2025 results: CA$0.022 loss per share (in line with FY 2024). Net loss: CA$1.89m (loss widened 54% from FY 2024). Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Aankondiging • Jun 25
Digital Commodities Capital Corp. announced that it expects to receive CAD 3 million in funding Digital Commodities Capital Corp. announced a non-brokered private placement of up to 20,000,000 units at a price of CAD 0..15 per Unit for aggregate gross proceeds of CAD 3,000,000 on June 25, 2025. Each Unit consists of one common share and one common share purchase warrant exercisable at a price of CAD 0.30 per share for a period of two years. Securities issued under the Financing will be subject to a statutory hold period of four months and one day in accordance with applicable securities laws and a concurrent four month hold period imposed under CSE policies, in each case, commencing on the date of issuance. Reported Earnings • Mar 16
Third quarter 2025 earnings released: CA$0.001 loss per share (vs CA$0.004 loss in 3Q 2024) Third quarter 2025 results: CA$0.001 loss per share (improved from CA$0.004 loss in 3Q 2024). Revenue: CA$23.5k (down 32% from 3Q 2024). Net loss: CA$150.0k (loss narrowed 27% from 3Q 2024). Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings. Aankondiging • Jan 30
The BC Bud Corporation announced that it has received CAD 1.649011 million in funding On January 29, 2025, The BC Bud Corporation closed the transaction. The company announced that it has issued 6,752,483 units at a price of CAD 0.075 per unit for gross proceeds of CAD 506,436.225 in its final tranche. To date, the Company has raised aggregate gross proceeds of CAD 1,649,011 through the sale of 21,986,813 Units. In connection with the third tranche of the Placement, the Company paid to certain finders an aggregate cash commission of $21,912; and issued to certain finders an aggregate of 292,160 finders warrants. All securities issued in the third tranche are subject to a statutory hold period expiring on May 30, 2025, in accordance with applicable securities legislation. Aankondiging • Jan 23
The BC Bud Corporation Announces Board Changes The BC Bud Corporation announced that it has appointed Ken Osborne to the Company's board of directors (the "Board"). Ken is a seasoned finance professional with deep expertise in mergers and acquisitions, capital markets, and strategic advisory. As a General Partner at Osborne Partners Ltd., he has led numerous successful transactions, including acquisitions, equity financings, and venture debt mandates across a range of industries. Previously, Ken was a key member of the M&A team at TELUS Corporation, where he managed 11 acquisitions spanning the telecom and agriculture technology sectors. A CFA Charterholder, Ken is based in Vancouver, BC. The Company has also accepted the resignation of Justin Chorbajian from the Board effective January 22, 2025. Aankondiging • Jan 10
The BC Bud Corporation announced that it expects to receive CAD 1 million in funding The BC Bud Corporation announced a a non-brokered private placement to issue 13,333,333 units at a price of CAD 0.075 per unit for proceeds of CAD 999,999.975 on January 9, 2025. Each unit will be composed of one common share and one share purchase warrant. Each warrant will entitle the holder to acquire an additional common share at a price of CAD 0.15 per share for a period of 24 months. No finders' fees are expected to be paid on any portion of the placement. The placement is expected to close around January 24, 2025. Board Change • Jan 03
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Director Justin Chorbajian was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Aankondiging • Jan 02
The BC Bud Corporation Announces Board Changes The BC Bud Corporation appointed Alyssa Barry to the Board of Directors. Alyssa Barry is the President of Alliance Advisors Investor Relations, joining through the 2024 acquisition of irlabs. With 20 years of capital markets and investor relations experience, Alyssa's expertise spans shareholder activism, corporate governance, and taking companies public in Canada and the US. She has raised over $1 billion in capital and previously served as Corporate Secretary of Artis REIT. In 2024, Alyssa was named one of Canada's Most Powerful Women: Top 100 by the Women's Executive Network (WXN) and recognized in Business in Vancouver's Top 40 Under 40. The company has also accepted the resignation of Brian Taylor from the Board of Directors effective December 30, 2024. New Risk • Nov 22
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 82% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 13% per year over the past 5 years. Shareholders have been substantially diluted in the past year (82% increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (CA$6.69m market cap, or US$4.78m). Aankondiging • Nov 21
The BC Bud Corporation announced that it has received CAD 0.375 million in funding On November 20, 2024. The BC Bud Corporation has closed the Transaction. Aankondiging • Nov 14
The BC Bud Corporation announced that it expects to receive CAD 0.375 million in funding The BC Bud Corporation announced a non-brokered private placement to issue 25,000,000 units at an issue price of CAD 0.015 per unit for the gross proceeds of CAD 375,000 on November 13, 2024. Each unit will comprise one common share and one share purchase warrant. Each warrant will entitle the holder to acquire an additional common share at a price of CAD 0.10 cents per share for a period of 24 months. No finders' fees are expected to be paid on any portion of the placement. Existing insiders of the company are expected to participate in the placement. The transaction is expected to close the financing on or around November 20, 2024. The securities issued pursuant to the offering will be subject to a hold period expiring four months and one day after the date of issuance. Completion of the placement remains subject to compliance with applicable securities laws and exchange policies. Aankondiging • Sep 10
The BC Bud Corporation, Annual General Meeting, Oct 29, 2024 The BC Bud Corporation, Annual General Meeting, Oct 29, 2024. New Risk • Aug 16
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended November 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (31% average weekly change). Earnings have declined by 24% per year over the past 5 years. Revenue is less than US$1m (CA$743k revenue, or US$542k). Market cap is less than US$10m (CA$1.54m market cap, or US$1.12m). Minor Risks Latest financial reports are more than 6 months old (reported November 2023 fiscal period end). Shareholders have been diluted in the past year (42% increase in shares outstanding). Aankondiging • May 08
The BC Bud Corporation Appoints Sean Flynn as Chief Commercial Officer The BC Bud Corporation announced the appointment of Sean Flynn as its new Chief Commercial Officer, effective May 7, 2024. In his new role, Mr. Flynn will be responsible for overseeing the Company's commercial operations and driving growth strategies. With over 30 years of experience in C-Suite roles in multi-national companies, Mr. Flynn brings a wealth of knowledge and expertise to The BC Bud Co. He is a Certified Franchise Executive since 2013 and a Lean Six Sigma Black Belt, demonstrating his commitment to excellence and continuous improvement. Throughout his career, Mr. Flynn has held leadership positions in Public and Private companies in Canada, the US, and in Asia, gaining a well-rounded appreciation of how to build brands and businesses. Prior to joining The BC Bud Co, Mr. Flynn provided consulting services in the areas of mergers &acquisitions, growth and turnaround strategies for businesses, corporate restructuring, business process improvement, and building operational excellence. Based in Vancouver, Canada, his clients included those in CPG retail, technology, food &beverage franchising, and accommodation sectors. Aankondiging • Apr 06
The BC Bud Corporation announced that it expects to receive CAD 0.4 million in funding The BC Bud Corporation announced a non-brokered private placement to issue 20,000,000 units at issue price CAD 0.02 per unit for gross proceeds of CAD 400,000 on April 5, 2024. Each unit consists of one common share and one warrant. Each warrant is will entitle holder to acquire additional common share of CAD 0.05 per share for a period of 24 months. The transaction is subject to exchange and regulatory approval. Reported Earnings • Jan 30
Third quarter 2024 earnings released: CA$0.006 loss per share (vs CA$0.004 loss in 3Q 2023) Third quarter 2024 results: CA$0.006 loss per share (further deteriorated from CA$0.004 loss in 3Q 2023). Revenue: CA$74.9k (down 54% from 3Q 2023). Net loss: CA$355.6k (loss widened 104% from 3Q 2023). New Risk • Nov 01
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$828k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$828k free cash flow). Share price has been highly volatile over the past 3 months (21% average weekly change). Earnings have declined by 33% per year over the past 5 years. Revenue is less than US$1m (CA$829k revenue, or US$598k). Market cap is less than US$10m (CA$2.83m market cap, or US$2.04m). Minor Risk Shareholders have been diluted in the past year (22% increase in shares outstanding). Aankondiging • Oct 17
The BC Bud Corporation Announces Resignation of Dayna Lange from Board of Directors The BC Bud Corporation announced that Dayna Lange has resigned from the Board of Directors of the Company effective October 16, 2023. The Company thanks Ms. Lange for her valuable contributions and wishes her success in her future endeavors. Aankondiging • Aug 26
The BC Bud Corporation, Annual General Meeting, Oct 27, 2023 The BC Bud Corporation, Annual General Meeting, Oct 27, 2023. New Risk • Jul 30
New major risk - Revenue and earnings growth Earnings have declined by 47% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (27% average weekly change). Earnings have declined by 47% per year over the past 5 years. Revenue is less than US$1m (CA$862k revenue, or US$652k). Market cap is less than US$10m (CA$4.01m market cap, or US$3.03m). Minor Risk Shareholders have been diluted in the past year (19% increase in shares outstanding). Aankondiging • Jul 29
The BC Bud Corporation announced that it expects to receive CAD 0.5 million in funding The BC Bud Corporation announced a non-brokered private placement to issue up to 6,666,667 units at an issue price of CAD 0.075 per unit for gross proceeds of CAD 500,000.025 on July 28, 2023. Each unit will comprise one common share and one share purchase warrant. Each warrant will entitle the holder to acquire an additional common share at a price of CAD 0.10 per share for a period of 36 months. Finder’s fees may be payable on all or any portion of the placement, which is subject to regulatory and exchange approval. Reported Earnings • Jul 28
First quarter 2024 earnings released: CA$0.003 loss per share (vs CA$0.011 loss in 1Q 2023) First quarter 2024 results: CA$0.003 loss per share (improved from CA$0.011 loss in 1Q 2023). Revenue: CA$197.6k (down 39% from 1Q 2023). Net loss: CA$149.7k (loss narrowed 70% from 1Q 2023). New Risk • Jun 28
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$1.5m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$1.5m free cash flow). Share price has been highly volatile over the past 3 months (24% average weekly change). Revenue is less than US$1m (CA$990k revenue, or US$751k). Market cap is less than US$10m (CA$4.28m market cap, or US$3.25m). Minor Risk Shareholders have been diluted in the past year (19% increase in shares outstanding). Aankondiging • May 19
The BC Bud Corporation Launches 6 New Products into British Columbia The BC Bud Corporation announced the launch of six new products, including two live hash rosin budders, two live hash rosin-infused BCBC flower PR strains, a Mosambi Live Hash Rosin Vape Cart, and Alaskan Thunder F (ATF) 2 x 1 g a pre roll flower SKU. The BC Bud Co. has partnered with Cedar Organics to create a full range of both solvent and solvent-free live concentrate products and formulations for direct delivery and provincial distribution. The two live hash rosin dab products, Mosambi Live Hash Rosin and Narang Tang Live Hash Rosin, are produced using traditional solventless techniques and are handcrafted from Cedar Organics' premium sun-grown cannabis. The two live hash rosin-infused BCBC flower PR strains, Mosambi Live Hash Rosin Infused BCBC Flower PR and Narang Tang Live Hash Rosin Infused BCBC Flower PR, provide a potent and flavorful experience. These strains are perfect for those who are looking for a more intense cannabis experience. The Mosambi Live Hash Rosin Vape Cart is a convenient and discreet way to consume this high-quality product. Made with 100% pure, full-spectrum cannabis extract, this vape cart delivers a smooth and flavorful experience for the premium cannabis category. Finally, the BCBC to launch their Alaskan Thunder F (ATF) 2 x 1g flower SKU into the BCLDB, a classic sativa cultivar well known from the legacy market. Aankondiging • Feb 04
The BC Bud Corporation announced that it has received CAD 0.34 million in funding The BC Bud Corporation announced a non-brokered private placement of 6,800,000 units at an issue price of CAD 0.05 per unit for the gross proceeds of CAD 340,000 on February 2, 2023. The transaction included participation returning individual investor, Karim Mohamedani for 2,000,000 units which represent 3.77% stake of the current issued and outstanding common shares of the company. Each Unit comprised one common share and one share purchase warrant. Each warrant entitles the holder to acquire an additional common share at a price of CAD 0.15 per share until February 2, 2025. All securities issuable in the transaction are subject to a four month hold period expiring on June 3, 2023 in accordance with applicable securities laws. No finder’s fees were payable in connection with the transaction. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Justin Chorbajian was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Aankondiging • Oct 19
The BC Bud Co Launches New Line of Edibles & Additional Pre-Rolls to Ontario Market The BC Bud Corporation announced the entry into the edibles market with the launch of Canna Beans and Canna Almonds into the OCS for fall along with additional pre-rolls. Canna Beans, a microdose confectionary edible, are made using beans from an award-winning roaster, which are taken through a swiss water decaffeination process and paired with sustainable, Belgian dark chocolate for a "custom doseable" experience. Canna Almonds, are a 2 pack of chocolate covered almonds at 5 mg THC per piece. In addition, Animal Cookies 1 gram pre-roll is also launching in Ontario at the same time. Aankondiging • Oct 13
The BC Bud Corporation Launches Two Live Resin Vape Cartridges into One of the Largest Cannabis Markets in Canada - Alberta The BC Bud Corporation announced the launch of its two live resin vape cartridges into one of the largest cannabis markets in Canada - Alberta. This marks the 6th province that carries The BC Bud Co's products. Aankondiging • Aug 24
The BC Bud Corporation, Annual General Meeting, Oct 17, 2022 The BC Bud Corporation, Annual General Meeting, Oct 17, 2022. Board Change • Jun 21
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Justin Chorbajian was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Aankondiging • Jun 16
The BC Bud Corporation Appoints Brian Taylor to the Board of Directors The BC Bud Corporation announced it has appointed Brian Taylor, currently an advisor to the Company, to the board of directors. Brian Taylor is a longstanding medical cannabis activist and politician in British Columbia. Mr. Taylorformed the British Columbia Marijuana Party in 1996 and was the first leader of the party during the 2001 provincial election. He has also advised countless cannabis initiatives over the past 4 decades. He is a two-term and current mayor of Grand Forks, British Columbia, and has been dubbed the "marijuana mayor". Brian Taylor was also the creator of the Cannabis Health Journal in 1997. Executive Departure • Oct 12
Director Corey Larricq has left the company On the 29th of September, Corey Larricq's tenure as Director ended after 2.7 years in the role. We don't have any record of a personal shareholding under Corey's name. Corey is the only executive to leave the company over the last 12 months. 